AU2003254902A1 - Myocardial cell protecting agents - Google Patents

Myocardial cell protecting agents

Info

Publication number
AU2003254902A1
AU2003254902A1 AU2003254902A AU2003254902A AU2003254902A1 AU 2003254902 A1 AU2003254902 A1 AU 2003254902A1 AU 2003254902 A AU2003254902 A AU 2003254902A AU 2003254902 A AU2003254902 A AU 2003254902A AU 2003254902 A1 AU2003254902 A1 AU 2003254902A1
Authority
AU
Australia
Prior art keywords
myocardial cell
protecting agents
cell protecting
agents
myocardial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003254902A
Inventor
Masahiro Amakawa
Reiko Ikegami
Takahiko Murata
Tadashi Ohyama
Haruyoshi Ueo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Publication of AU2003254902A1 publication Critical patent/AU2003254902A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003254902A 2002-08-09 2003-08-08 Myocardial cell protecting agents Abandoned AU2003254902A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-234029 2002-08-09
JP2002234029 2002-08-09
PCT/JP2003/010158 WO2004014412A1 (en) 2002-08-09 2003-08-08 Myocardial cell protecting agents

Publications (1)

Publication Number Publication Date
AU2003254902A1 true AU2003254902A1 (en) 2004-02-25

Family

ID=31711884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003254902A Abandoned AU2003254902A1 (en) 2002-08-09 2003-08-08 Myocardial cell protecting agents

Country Status (3)

Country Link
JP (1) JPWO2004014412A1 (en)
AU (1) AU2003254902A1 (en)
WO (1) WO2004014412A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2005039625A1 (en) * 2003-10-28 2005-05-06 Rheoscience A/S Growth hormone secretagogue receptor agonists
US20090053334A1 (en) 2006-01-31 2009-02-26 Nat. Uni. Corp. Hokkaido University Ghrelin production promoter
KR20090107088A (en) 2007-02-09 2009-10-12 트랜자임 파르마 인크 Macrocyclic ghrelin receptor modulators and methods of using the same
BRPI0911622B8 (en) 2008-04-28 2021-05-25 Janssen Pharmaceutica Nv benzoxepine and benzocycloheptane derivatives, their preparation process, their use and pharmaceutical composition comprising them
US9078868B2 (en) 2010-01-15 2015-07-14 University Of Miyazaki Therapeutic agent for accelerating recovery of animal under medical treatment
JP7430442B2 (en) * 2019-12-27 2024-02-13 クラシエ株式会社 Ghrelin receptor activator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0554381T3 (en) * 1990-10-25 1996-04-09 Genentech Inc Use of protective agents against reactive oxygen compounds
SE9703929D0 (en) * 1996-11-22 1997-10-28 Pharmacia & Upjohn Ab Therapeutic use and method
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
ATE304373T1 (en) * 1999-12-28 2005-09-15 Kaken Pharma Co Ltd NERVOUS PROTECTIVES
EP1297839A4 (en) * 2000-06-23 2005-12-07 Kaken Pharma Co Ltd Preventives or remedies for heart failure

Also Published As

Publication number Publication date
JPWO2004014412A1 (en) 2005-12-02
WO2004014412A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2003206028A1 (en) Antidiabetic agents
AU2003265826A1 (en) Electrolyte
AU2003288586A1 (en) Electrode arrangement
AU2003279056A1 (en) Improved hydrogen storage materials
AUPS088702A0 (en) Electrolyte purgative
AU2003213065A1 (en) Novel insect cell line
AU2003242125A1 (en) Stereo-light double-junction photovolatic cell
AU2003270297A1 (en) Toolholder
AU2003268304A1 (en) Toolholder
AU2003294726A1 (en) Window-winding arrangement
AU2003242258A1 (en) Battery
AU2003292408A1 (en) Deployable structure
GB0206357D0 (en) Cells
AU2003263502A1 (en) Storage
AU2003254902A1 (en) Myocardial cell protecting agents
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2003235122A1 (en) Cell death inhibitor
AU2002354472A1 (en) Combine
AU2002329533A1 (en) Battery holder
AU2003244148A1 (en) Antifungal agents for external use
AU2003269185A1 (en) Software protection
AU2002355026A1 (en) Combine
AU2003215804A1 (en) Antidiabetic agents
AU2003261666A1 (en) Pack assembly
AU2003303051A1 (en) Cell death inhibitor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase